Following promising clinical results, retatrutide, a novel peptide option for treating type 2 hyperglycemia , has received regulatory approval from Great Britain's Healthcare and Regulatory Agency ( MHRA https://luchzpj271998.loginblogin.com/49386265/retatrutide-medication-peptide-uk-approval-and-availability